Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × Liver Neoplasms × Clear all

Phase

Status

Sponsor Class

OTHER 117 INDUSTRY 34 NIH 20 NETWORK 3 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3 Lipoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Osteosarcoma 1 Neutropenia 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Cancer Cachexia 1 Breast Neoplasms 1 Barrett Esophagus 1 Anemia 1

Interventions

Everolimus 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡